- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Adult growth hormone deficiency
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 601KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 147KB)
Somapacitan – March 2022
Somapacitan: Injection 10 mg in 1.5 mL pre-filled pen; Sogroya®
Last updated
1 July 2022